Outlook Therapeutics (OTLK) Change in Account Payables: 2015-2024
Historic Change in Account Payables for Outlook Therapeutics (OTLK) over the last 10 years, with Sep 2024 value amounting to $1.4 million.
- Outlook Therapeutics' Change in Account Payables fell 495.45% to -$2.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$1.5 million, marking a year-over-year decrease of 11.87%. This contributed to the annual value of $1.4 million for FY2024, which is 54.78% down from last year.
- According to the latest figures from FY2024, Outlook Therapeutics' Change in Account Payables is $1.4 million, which was down 54.78% from $3.1 million recorded in FY2023.
- Over the past 5 years, Outlook Therapeutics' Change in Account Payables peaked at $3.1 million during FY2023, and registered a low of -$1.5 million during FY2020.
- Its 3-year average for Change in Account Payables is $1.9 million, with a median of $1.4 million in 2024.
- In the last 5 years, Outlook Therapeutics' Change in Account Payables surged by 752.56% in 2022 and then slumped by 54.78% in 2024.
- Outlook Therapeutics' Change in Account Payables (Yearly) stood at -$1.5 million in 2020, then soared by 86.68% to -$198,469 in 2021, then spiked by 752.56% to $1.3 million in 2022, then skyrocketed by 138.05% to $3.1 million in 2023, then slumped by 54.78% to $1.4 million in 2024.